Business Model ― Value Creation Process
As part of an effort to fulfill its Corporate Mission, Sumitomo Pharma is addressing its material issues (materiality) for CSR-based management through business activities that utilize its three strengths of research and development capabilities, human resources, and global platform. By creating innovative pharmaceutical products and healthcare solutions, we provide unique values to society, including quality of life (QOL) improvements for patients and their families. Through these initiatives, we aim to continuously better our corporate value, thus establishing our position as a "Global Specialized Player."
Check here for "Integrated Report 2022"